[TNF-inhibitors slow down joint destruction in rheumatoid arthritis. No cure, but dramatic relief of symptoms].
Wollheim
F A
FA
Reumatologiska kliniken, Universitetssjukhuset i Lund. Frank.Wollheim@reum.lu.se
D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000191:economics / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D006801:Humans; D007596:Joints / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D018124:Receptors, Tumor Necrosis Factor / Q000187:drug effects; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha